Kesmodel, S., Ellis, L., Lin, E., Chang, G., Abdalla, E., Kopetz, S., . . . Feig, B. (2008). Preoperative Bevacizumab Does Not Significantly Increase Postoperative Complication Rates in Patients Undergoing Hepatic Surgery for Colorectal Cancer Liver Metastases.
Chicago Style (17th ed.) CitationKesmodel, Susan, et al. Preoperative Bevacizumab Does Not Significantly Increase Postoperative Complication Rates in Patients Undergoing Hepatic Surgery for Colorectal Cancer Liver Metastases. 2008.
MLA (9th ed.) CitationKesmodel, Susan, et al. Preoperative Bevacizumab Does Not Significantly Increase Postoperative Complication Rates in Patients Undergoing Hepatic Surgery for Colorectal Cancer Liver Metastases. 2008.
Warning: These citations may not always be 100% accurate.